190 related articles for article (PubMed ID: 38779619)
1. Editorial: Recent advances in discovering molecular targets for cancer therapy.
Yang Z; Wang T
Front Med (Lausanne); 2024; 11():1403466. PubMed ID: 38779619
[No Abstract] [Full Text] [Related]
2. CanImmunother: a manually curated database for identification of cancer immunotherapies associating with biomarkers, targets, and clinical effects.
Zhang W; Zeng B; Lin H; Guan W; Mo J; Wu S; Wei Y; Zhang Q; Yu D; Li W; Chan GC
Oncoimmunology; 2021; 10(1):1944553. PubMed ID: 34345532
[TBL] [Abstract][Full Text] [Related]
3. Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy.
Chiang AWT; Baghdassarian HM; Kellman BP; Bao B; Sorrentino JT; Liang C; Kuo CC; Masson HO; Lewis NE
J Biomed Sci; 2021 Jun; 28(1):50. PubMed ID: 34158025
[TBL] [Abstract][Full Text] [Related]
4. Application of immune checkpoint inhibitors in immunotherapy for gastric cancer.
Wu YX; Zhou XY; Wang JQ; Chen GM; Chen JX; Wang RC; Huang JQ; Chen JS
Immunotherapy; 2023 Feb; 15(2):101-115. PubMed ID: 36597704
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets.
Naik A; Yeong J; Decock J
Front Oncol; 2022; 12():1075329. PubMed ID: 36439489
[No Abstract] [Full Text] [Related]
6. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines.
Hashemzadeh N; Dolatkhah M; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidi Y; Barar J
Life Sci; 2021 Apr; 271():119110. PubMed ID: 33513401
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.
Lan Z; Li X; Zhang X
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474286
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Recent advances and challenges in cancer immunotherapies for patients with autoimmune diseases.
Saleh R
Front Immunol; 2022; 13():1127739. PubMed ID: 36700231
[No Abstract] [Full Text] [Related]
9. Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers.
Lin Z; Ji Y; Zhou J; Li G; Wu Y; Liu W; Li Z; Liu T
Cancer Lett; 2023 Jul; 566():216245. PubMed ID: 37247772
[TBL] [Abstract][Full Text] [Related]
10. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
11. Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers.
Spiliopoulou P; Vornicova O; Genta S; Spreafico A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674809
[TBL] [Abstract][Full Text] [Related]
12. Advances in drug treatments for mesothelioma.
Zucali PA; De Vincenzo F; Perrino M; Digiacomo N; Cordua N; D'Antonio F; Borea F; Fazio R; Pirozzi A; Santoro A
Expert Opin Pharmacother; 2022 Jun; 23(8):929-946. PubMed ID: 35508368
[TBL] [Abstract][Full Text] [Related]
13. A new era in cancer immunotherapy: discovering novel targets and reprogramming the immune system.
Chiriva-Internati M; Bot A
Int Rev Immunol; 2015 Mar; 34(2):101-3. PubMed ID: 25901856
[No Abstract] [Full Text] [Related]
14. Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.
Cai H; Li M; Deng R; Wang M; Shi Y
Biomark Res; 2022 Aug; 10(1):67. PubMed ID: 36042469
[TBL] [Abstract][Full Text] [Related]
15. Editorial: New immunotherapy strategies and related therapeutic targets for gastrointestinal malignancies.
Ramamoorthi G
Front Immunol; 2024; 15():1389781. PubMed ID: 38524142
[No Abstract] [Full Text] [Related]
16. [Advances of immunotherapy-related biomarker in esophageal carcinoma].
Zhang RX; Kang XZ; Zheng QF; Wang Z; Chen XK; Li Y; Qin JJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):396-400. PubMed ID: 37072320
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Sepsis Induced by Infections: Clinical Evidence and Potential Targets.
Huang SJ; Ai T; Hu H; Wang J; Wang JL
Discov Med; 2022; 34(172):83-95. PubMed ID: 36281029
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Recent Advances in In Vitro and In Vivo Multi-Omics Analyses of Extracellular Vesicles: Therapeutic Targets and Biomarkers.
Manfredi M; Williams E; Cho WC; Falasca M
Front Mol Biosci; 2021; 8():784436. PubMed ID: 34778382
[No Abstract] [Full Text] [Related]
19. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade.
Sun B; Xun Z; Zhang N; Liu K; Chen X; Zhao H
Cancer Cell Int; 2023 Dec; 23(1):313. PubMed ID: 38066642
[TBL] [Abstract][Full Text] [Related]
20. Update in Lung Cancer 2014.
Spira A; Halmos B; Powell CA
Am J Respir Crit Care Med; 2015 Aug; 192(3):283-94. PubMed ID: 26230235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
